Categories AlphaGraphs, Earnings, Finance

Charles Schwab (SCHW) Q3 earnings top expectations; revenues up 20%

Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Monday reported higher earnings and revenues for the third quarter of 2022. The results also exceeded Wall Street’s forecast.

Charles Schwab Q3 2022 earnings infographic

Total revenues increased 20% year-over-year to $5.50 billion in the third quarter of fiscal 2022. The number also came in above Wall Street’s estimates.

Net profit, on an adjusted basis, moved up to $1.10 per share in the three-month period from $0.84 per share in the comparable quarter of last year. Unadjusted net income was $2.02 billion or $0.99 per share, compared to $1.53 billion or $0.74 per share in the year-ago quarter. Analysts had predicted slower growth.


Check this space to read management/analysts’ comments on Charles Schwab’s Q3 2022 results


“Schwab’s performance during the third quarter reflected the continued success of our “Through Clients’ Eyes” strategy and our contemporary full-service approach to helping clients achieve their financial goals. As we assisted investors with navigating persistent macroeconomic headwinds, we continued to drive robust business growth. Bolstered by record third quarter retail inflows, core net new assets equaled $115 billion for the period – a 7% annualized growth rate,” said Walt Bettinger, CEO of Charles Schwab.

Prior Performance

  • The Charles Schwab Corporation Q2 2022 Earnings Infographic
  • The Charles Schwab Corporation Q1 2022 earnings infographic
  • The Charles Schwab Corporation Q4 2021 earnings infographic
  • The Charles Schwab Corporation Q3 2021 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top